Immunity boosting treatment enhances CAR-T cell therapy for blood cancers
A new study shows that treatment with an immunity boosting protein called interleukin 7 (IL-7) after an infusion of genetically modified T cells causes the cancer-fighting CAR-T cells to grow in number and become more effective at killing tumor cells. …read more
